Arifon® Retard (indapamide)

29.07.2013 Updated 22.10.2019 6428 views

By MoH of Ukraine order No. 574 of 05.07.13, the instructions for medical use (hereinafter – the instructions) of the original (reference) medicinal product containing indapamide, namely the medicinal product Arifon® Retard, prolonged-release tablets, were approved, with amendments and additions to the following sections of the instructions: “Adverse reactions,” “Special warnings and precautions for use,” “Interaction with other medicinal products and other forms of interaction.”